ng-nitroarginine methyl ester has been researched along with Myocarditis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 3 (23.08) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, GL; Han, LN; He, S; Liu, JW; Wang, YT; Zou, X | 1 |
| Abidali, A; Biwer, LA; D'souza, KM; DeBoth, M; Hale, TM; Huentelman, M; Siniard, AL; Tu, D | 1 |
| Hattori, M; Kishimoto, C; Okabe, TA; Yuan, Z | 1 |
| Fujita, M; Hattori, M; Kishimoto, C; Mikami, Y; Okabe, TA; Shimada, K | 1 |
| Hiraoka, Y; Kishimoto, C; Ochiai, H; Takada, H | 1 |
| Glück, B; Görlach, M; Henke, A; Markgraf, R; Schmidtke, M; Sigusch, HH; Stelzner, A; Zell, R | 1 |
| Chopin, C; Depontieu, F; Lancel, S; Marechal, X; Mordon, S; Neviere, R; Scherpereel, A; Tissier, S | 1 |
| Chao, J; Chao, L; Yin, H | 1 |
| Allen, G; Herskowitz, A; Hill, SL; Lafond-Walker, A; Landavere, M; Lowenstein, CJ; Rose, NR; Wu, J | 1 |
| Hiraoka, Y; Kishimoto, C; Kurokawa, M; Nakamura, M; Ochiai, H; Shiraki, K; Takada, H | 1 |
| Matsui, S; Matsumori, A; Okada, I; Sasayama, S; Sato, Y; Shioi, T; Shiota, K; Suzuki, H; Wang, WZ; Yamada, T | 1 |
| Hayashi, Y; Hirata, K; Hotta, H; Itoh, H; Kanazawa, K; Kawashima, S; Mikami, S; Yokoyama, M | 1 |
| Bingisser, R; Eriksson, U; Eugster, HP; Follath, F; Kurrer, MO; Marsch, S; Saremaslani, P; Widmer, U | 1 |
13 other study(ies) available for ng-nitroarginine methyl ester and Myocarditis
| Article | Year |
|---|---|
[Study of L-NAME treatment on experimental autoimmune myocarditis].
Topics: Animals; Apoptosis; Autoimmune Diseases; Caspase 3; Caspase 8; Caspase 9; Disease Models, Animal; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocytes, Cardiac; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II | 2013 |
Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arterial Pressure; Cell Proliferation; Chemokine CCL2; Chemokines; Cytokines; Disease Progression; Enalapril; Enzyme Inhibitors; Interleukin-10; Interleukin-6; Macrophages; Male; Myocarditis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred SHR | 2016 |
L-arginine ameliorates experimental autoimmune myocarditis by maintaining extracellular matrix and reducing cytotoxic activity of lymphocytes.
Topics: Animals; Arginine; Autoimmune Diseases; Cytotoxicity Tests, Immunologic; Extracellular Matrix; Lymphocytes; Mice; Mice, Inbred C57BL; Models, Animal; Myocarditis; Myocardium; Myosins; NG-Nitroarginine Methyl Ester; Nitric Oxide; Swine | 2008 |
Therapy with granulocyte colony-stimulating factor in the chronic stage, but not in the acute stage, improves experimental autoimmune myocarditis in rats via nitric oxide.
Topics: Acute Disease; Animals; Autoimmune Diseases; Cardiac Myosins; Chronic Disease; Cytokines; Echocardiography; Enzyme Inhibitors; Granulocyte Colony-Stimulating Factor; Humans; Immunization; Immunoenzyme Techniques; Myocarditis; Neovascularization, Pathologic; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Inbred Lew; Recombinant Proteins; Superoxides; Swine | 2010 |
Oral L-arginine prevents murine coxsackievirus B3 myocarditis.
Topics: Administration, Oral; Animals; Arginine; Coxsackievirus Infections; Disease Models, Animal; Enterovirus B, Human; Enzyme Inhibitors; Male; Mice; Mice, Inbred C3H; Myocarditis; NG-Nitroarginine Methyl Ester; Severity of Illness Index; Survival Rate | 2002 |
Nitric oxide donors inhibit the coxsackievirus B3 proteinases 2A and 3C in vitro, virus production in cells, and signs of myocarditis in virus-infected mice.
Topics: 3C Viral Proteases; Animals; Cell Line; Cysteine Endopeptidases; Enterovirus B, Human; Enterovirus Infections; HeLa Cells; Humans; Isosorbide Dinitrate; Mice; Myocarditis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroglycerin; Penicillamine; Viral Proteins; Virus Replication | 2004 |
Peroxynitrite decomposition catalysts prevent myocardial dysfunction and inflammation in endotoxemic rats.
Topics: Animals; Biomarkers; Catalysis; Disease Models, Animal; Endothelium, Vascular; Endotoxemia; Enzyme Inhibitors; Fluorescent Dyes; Guanidines; I-kappa B Proteins; Leukocytes; Metalloporphyrins; Models, Cardiovascular; Myocarditis; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Peroxynitrous Acid; Rats; Rats, Sprague-Dawley; Tumor Necrosis Factor-alpha; Tyrosine; Xanthenes | 2004 |
Nitric oxide mediates cardiac protection of tissue kallikrein by reducing inflammation and ventricular remodeling after myocardial ischemia/reperfusion.
Topics: Adenoviridae; Animals; Bradykinin; Bradykinin B2 Receptor Antagonists; Enzyme Inhibitors; Gene Expression; Gene Transfer Techniques; Heart Function Tests; Heart Ventricles; Hemodynamics; Humans; Kallikreins; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Myocarditis; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Phosphorylation; Rats; Rats, Wistar; Receptor, Bradykinin B2; Ventricular Remodeling | 2008 |
Nitric oxide inhibits viral replication in murine myocarditis.
Topics: Amino Acid Sequence; Animals; Antibodies; Arginine; Cell Line; Cells, Cultured; Coxsackievirus Infections; Enterovirus B, Human; Enzyme Induction; Enzyme Inhibitors; Immunohistochemistry; Isoenzymes; Macrophage Activation; Macrophages; Mice; Mice, Inbred Strains; Molecular Sequence Data; Myocarditis; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Peptide Fragments; Rabbits; Spleen; Transcription, Genetic; Virus Replication | 1996 |
Nitric oxide and murine coxsackievirus B3 myocarditis: aggravation of myocarditis by inhibition of nitric oxide synthase.
Topics: Animals; Coxsackievirus Infections; Enterovirus B, Human; Enzyme Inhibitors; Macrophages; Mice; Myocarditis; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Viremia; Virus Replication | 1996 |
Beneficial effects of amlodipine in a murine model of congestive heart failure induced by viral myocarditis. A possible mechanism through inhibition of nitric oxide production.
Topics: Amlodipine; Animals; Body Weight; Calcium Channel Blockers; Cardiovirus Infections; Disease Models, Animal; Encephalomyocarditis virus; Heart; Heart Failure; Male; Mice; Mice, Inbred DBA; Myocarditis; NG-Nitroarginine Methyl Ester; Nitric Oxide; Organ Size | 1997 |
Low-dose N omega-nitro-L-arginine methyl ester treatment improves survival rate and decreases myocardial injury in a murine model of viral myocarditis induced by coxsackievirus B3.
Topics: Animals; Blood Pressure; Coxsackievirus Infections; Dinoprostone; Enterovirus; Enzyme Inhibitors; Heart; Male; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Reference Values; Survival Analysis | 1997 |
Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction.
Topics: Adjuvants, Immunologic; Animals; Autoimmune Diseases; CD4-Positive T-Lymphocytes; Cell Division; Dose-Response Relationship, Drug; Enzyme Induction; Enzyme Inhibitors; Immunity, Cellular; Immunohistochemistry; Inflammation; Interferon gamma Receptor; Interferon-gamma; Male; Mice; Mice, Inbred BALB C; Mice, Mutant Strains; Myocarditis; Myocardium; Myosin Heavy Chains; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Receptors, Interferon; Severity of Illness Index | 2001 |